|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
JST031308228 |
003 |
DE-627 |
005 |
20240620200546.0 |
007 |
cr uuu---uuuuu |
008 |
150324s1998 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.2307/3434178
|2 doi
|
035 |
|
|
|a (DE-627)JST031308228
|
035 |
|
|
|a (JST)3434178
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Miller, Alexandra C.
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Transformation of Human Osteoblast Cells to the Tumorigenic Phenotype by Depleted Uranium-Uranyl Chloride
|
264 |
|
1 |
|c 1998
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Depleted uranium (DU) is a dense heavy metal used primarily in military applications. Although the health effects of occupational uranium exposure are well known, limited data exist regarding the long-term health effects of internalized DU in humans. We established an in vitro cellular model to study DU exposure. Microdosimetric assessment, determined using a Monte Carlo computer simulation based on measured intracellular and extracellular uranium levels, showed that few (0.0014%) cell nuclei were hit by alpha particles. We report the ability of DU-uranyl chloride to transform immortalized human osteoblastic cells (HOS) to the tumorigenic phenotype. DU-uranyl chloride-transformants are characterized by anchorage-independent growth, tumor formation in nude mice, expression of high levels of the k-ras oncogene, reduced production of the Rb tumor-suppressor protein, and elevated levels of sister chromatid exchanges per cell. DU-uranyl chloride treatment resulted in a 9.6 (± 2.8)-fold increase in transformation frequency compared to untreated cells. In comparison, nickel sulfate resulted in a 7.1 (± 2.1)-fold increase in transformation frequency. This is the first report showing that a DU compound caused human cell transformation to the neoplastic phenotype. Although additional studies are needed to determine if protracted DU exposure produces tumors in vivo, the implication from these in vitro results is that the risk of cancer induction from internalized DU exposure may be comparable to other biologically reactive and carcinogenic heavy-metal compounds (e.g., nickel).
|
650 |
|
4 |
|a Alpha radiation
|
650 |
|
4 |
|a Depleted uranium
|
650 |
|
4 |
|a Osteoblast
|
650 |
|
4 |
|a Transformation
|
650 |
|
4 |
|a Physical sciences
|x Chemistry
|x Chemical elements
|x Metals
|x Uranium
|
650 |
|
4 |
|a Biological sciences
|x Biology
|x Cytology
|x Cell biology
|x Cells
|x Cultured cells
|x Cell lines
|x Transformed cell line
|
650 |
|
4 |
|a Health sciences
|x Medical conditions
|x Diseases
|x Neoplasia
|x Tumors
|
650 |
|
4 |
|a Physical sciences
|x Chemistry
|x Chemical compounds
|x Functional groups
|x Acetates
|x Lead acetates
|
650 |
|
4 |
|a Physical sciences
|x Physics
|x Microphysics
|x Particle physics
|x Subatomic particles
|x Bosons
|x Alpha particles
|
650 |
|
4 |
|a Health sciences
|x Health and wellness
|x Public health
|x Health hazards
|x Chemical hazards
|
650 |
|
4 |
|a Biological sciences
|x Biology
|x Cytology
|x Cell biology
|x Cells
|x Cultured cells
|x Cell lines
|
650 |
|
4 |
|a Biological sciences
|x Biology
|x Cytology
|x Cell biology
|x Cells
|x Cultured cells
|x Cell lines
|x Tumor cell line
|
650 |
|
4 |
|a Biological sciences
|x Biology
|x Genetics
|x Phenotypes
|
650 |
|
4 |
|a Physical sciences
|x Chemistry
|x Chemical compounds
|x Halogen compounds
|x Chlorine compounds
|x Chlorides
|x Research
|
655 |
|
4 |
|a research-article
|
700 |
1 |
|
|a Blakely, William F.
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Livengood, David
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Whittaker, Tim
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xu, Jiaquan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ejnik, John W.
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hamilton, Matthew M.
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Parlette, Eric
|e verfasserin
|4 aut
|
700 |
1 |
|
|a St. John, Theodore
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gerstenberg, Henry M.
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hsu, Hannah
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Environmental Health Perspectives
|d National Institute of Environmental Health Sciences. National Institutes of Health. Department of Health, Education and Welfare, 1972
|g 106(1998), 8, Seite 465-471
|w (DE-627)34134639X
|w (DE-600)2067353-X
|x 00916765
|7 nnns
|
773 |
1 |
8 |
|g volume:106
|g year:1998
|g number:8
|g pages:465-471
|
856 |
4 |
0 |
|u https://www.jstor.org/stable/3434178
|3 Volltext
|
856 |
4 |
0 |
|u https://doi.org/10.2307/3434178
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_JST
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_23
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_73
|
912 |
|
|
|a GBV_ILN_74
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_95
|
912 |
|
|
|a GBV_ILN_100
|
912 |
|
|
|a GBV_ILN_101
|
912 |
|
|
|a GBV_ILN_105
|
912 |
|
|
|a GBV_ILN_110
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_161
|
912 |
|
|
|a GBV_ILN_170
|
912 |
|
|
|a GBV_ILN_206
|
912 |
|
|
|a GBV_ILN_213
|
912 |
|
|
|a GBV_ILN_230
|
912 |
|
|
|a GBV_ILN_285
|
912 |
|
|
|a GBV_ILN_293
|
912 |
|
|
|a GBV_ILN_370
|
912 |
|
|
|a GBV_ILN_374
|
912 |
|
|
|a GBV_ILN_602
|
912 |
|
|
|a GBV_ILN_702
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2011
|
912 |
|
|
|a GBV_ILN_2014
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2020
|
912 |
|
|
|a GBV_ILN_2021
|
912 |
|
|
|a GBV_ILN_2026
|
912 |
|
|
|a GBV_ILN_2027
|
912 |
|
|
|a GBV_ILN_2044
|
912 |
|
|
|a GBV_ILN_2050
|
912 |
|
|
|a GBV_ILN_2057
|
912 |
|
|
|a GBV_ILN_2061
|
912 |
|
|
|a GBV_ILN_2107
|
912 |
|
|
|a GBV_ILN_2190
|
912 |
|
|
|a GBV_ILN_2943
|
912 |
|
|
|a GBV_ILN_2946
|
912 |
|
|
|a GBV_ILN_2949
|
912 |
|
|
|a GBV_ILN_2951
|
912 |
|
|
|a GBV_ILN_4012
|
912 |
|
|
|a GBV_ILN_4035
|
912 |
|
|
|a GBV_ILN_4037
|
912 |
|
|
|a GBV_ILN_4046
|
912 |
|
|
|a GBV_ILN_4112
|
912 |
|
|
|a GBV_ILN_4125
|
912 |
|
|
|a GBV_ILN_4126
|
912 |
|
|
|a GBV_ILN_4242
|
912 |
|
|
|a GBV_ILN_4249
|
912 |
|
|
|a GBV_ILN_4251
|
912 |
|
|
|a GBV_ILN_4305
|
912 |
|
|
|a GBV_ILN_4306
|
912 |
|
|
|a GBV_ILN_4307
|
912 |
|
|
|a GBV_ILN_4313
|
912 |
|
|
|a GBV_ILN_4322
|
912 |
|
|
|a GBV_ILN_4323
|
912 |
|
|
|a GBV_ILN_4324
|
912 |
|
|
|a GBV_ILN_4325
|
912 |
|
|
|a GBV_ILN_4335
|
912 |
|
|
|a GBV_ILN_4338
|
912 |
|
|
|a GBV_ILN_4346
|
912 |
|
|
|a GBV_ILN_4367
|
912 |
|
|
|a GBV_ILN_4393
|
912 |
|
|
|a GBV_ILN_4700
|
951 |
|
|
|a AR
|
952 |
|
|
|d 106
|j 1998
|e 8
|h 465-471
|